Eli Lilly’s weight loss drug Zepbound has shown significant benefits in patients with a common type of heart failure and obesity, as per the late-stage trial data released by the company. The findings reveal that Zepbound, along with other popular GLP-1 drugs, offers health advantages beyond weight loss promotion and blood sugar regulation. The study
0 Comments
Wayfair, an online home goods company, experienced a decline in sales during its fiscal second quarter. CEO Niraj Shah attributed this decline to a current slowdown in the home goods category that he described as “unprecedented.” Shah even went so far as to liken the current situation to the 2008 financial crisis. This comparison is
0 Comments